We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Michael Koch

Michael O Koch MD, FACS

John P. Donohue Professor and Chair, Department of Urology, Indiana University School of Medicine, Director Urology Service Line, IU Health, Indianapolis, Indianapolis, IN

Recent Contributions to PracticeUpdate:

  1. Clinicopathological Features and Survival Outcomes of Plasmacytoid Variant Urothelial Carcinoma of the Bladder
  2. Long-Term Oncological Outcomes of Patients With Paratesticular Sarcoma
  3. The Use of MRI to Predict Oncological Control Among Candidates for Focal Ablation of Prostate Cancer
  4. Gender-Specific Differences in Recurrence of Non–Muscle Invasive Bladder Cancer
  5. Circulating Tumor Cells in Patients With Variant Urothelial Carcinoma Histology Treated With Radical Cystectomy
  6. Pretreatment Lymphocytopenia in Muscle-Invasive and Advanced Bladder Cancer
  7. Focal Ablation Targeted to the Index Lesion in Localized Prostate Cancer
  8. Effectiveness and Safety of Extended-Duration Prophylaxis for Venous Thromboembolism in Major Urologic Oncology Surgery
  9. Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-Based Chemotherapy in Muscle-Invasive Bladder Cancer

Most Read This Week

Recently Updated